Capital Investment Counsel, LLC

Position in JNJ — Johnson & Johnson

CIK 2033609 DENVER, CO

Position in JNJ

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$327,621

+$12,294 QoQ

Shares Held

1,290

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

#4,085

of 4,664 holders

Holding Since

Sep 2024

6 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Capital Investment Counsel, LLC holds $30,068,995 across 6 Drug Manufacturers - General names. JNJ ranks #5 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	49,388	$12,427,996
2	AMGN	Amgen Inc	20,071	$7,268,110
3	GILD	Gilead Sciences, Inc.	49,570	$6,262,673
4	LLY	ELI LILLY & Co	2,935	$3,520,327
5	JNJ	Johnson & Johnson This page	1,290	$327,621
6	MRK	Merck & Co., Inc.	2,041	$262,268

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$327,621	1,290	0.0%	Shares	Sole	2026-07-15
2026-03-31	$315,327	1,290	-0.5%	Shares	Sole	2026-04-23
2025-12-31	$268,207	1,296	+5.0%	Shares	Sole	2026-02-02
2025-09-30	$228,808	1,234	-9.1%	Shares	Sole	2025-11-06
2025-03-31	$225,210	1,358	+7.6%	Shares	Sole	2025-05-15
2024-09-30	$204,519	1,262	—	Shares	Sole	2024-11-12
No filing history on record for this holder in this stock.